Urolithin A and Creatine as A Dual Mitochondrial–Bioenergetic Intervention against Exercise-Induced Skeletal Muscle Injury in Rats
Downloads
Background: Eccentric-biased exercise can produce delayed force loss, membrane leakage, redox imbalance, inflammatory signaling and transient mitochondrial dysfunction. Urolithin A (UA) promotes mitochondrial quality control, whereas creatine strengthens the creatine–phosphocreatine energy-buffering system. Methods: Seventy-two adult Wistar rats (36 male, 36 female) were allocated to sedentary control (SED-CON), sedentary UA plus creatine (SED-UA+Cr), exercise control (EX-CON), exercise plus UA (EX-UA), exercise plus creatine (EX-Cr), or exercise plus UA and creatine (EX-UA+Cr) groups (n=12/group). UA was administered orally at 25 mg/kg/day and creatine monohydrate was incorporated into diet at 2% (w/w) for 28 days before a single 90-min downhill run (16 m/min, −16°); supplementation continued through 48 h of recovery. Grip force, serum creatine kinase (CK) and lactate dehydrogenase (LDH) were assessed serially. At 48 h, skeletal muscle ATP, total creatine, lactate, glycogen, citrate synthase, respiratory-chain Complex I/II activities, redox markers, cytokines and mitochondrial quality-control/biogenesis transcripts were quantified. Results: Downhill running reduced 48-h grip force to 77.0 ± 3.8% of baseline in EX-CON. Recovery was greater with UA (88.5 ± 4.7%), creatine (90.9 ± 3.7%) and UA+creatine (96.1 ± 6.2%); the combination differed from EX-CON by 19.1 percentage points (95% CI 14.7–23.6, P<0.0001). CK AUC0–48h fell from 85,149 ± 4,901 to 40,027 ± 2,776 U·h/L with the combination (P<0.0001). Compared with EX-CON, EX-UA+Cr preserved ATP (4.46 ± 0.38 vs 2.84 ± 0.24 nmol/mg wet tissue), increased total muscle creatine (42.75 ± 3.18 vs 29.25 ± 2.75 µmol/g), restored Complex I activity (99.2 ± 8.6 vs 66.6 ± 8.3 nmol/min/mg protein), lowered malondialdehyde and pro-inflammatory cytokines, increased IL-10, and produced the largest increases in Pink1, Park2, Ppargc1a, Tfam and Nrf1 transcript abundance. Grip-force recovery correlated positively with ATP (Spearman ρ=0.76, P<0.0001) and inversely with CK AUC (ρ=−0.78, P<0.0001). Conclusion: UA and creatine provided complementary protection against eccentric-biased exercise injury, linking faster functional recovery with preservation of muscle energy status, mitochondrial enzyme activity, redox balance and inflammatory control. The combination consistently produced the strongest recovery phenotype, although formal interaction effects were outcome-dependent.
[1] R. B. Armstrong, R. W. Ogilvie, and J. A. Schwane, “Eccentric exercise-induced injury to rat skeletal muscle,” Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology, vol. 54, no. 1, pp. 80–93, 1983, doi: 10.1152/jappl.1983.54.1.80.
[2] J. A. Schwane and R. B. Armstrong, “Effect of training on skeletal muscle injury from downhill running in rats,” Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology, vol. 55, no. 3, pp. 969–975, 1983, doi: 10.1152/jappl.1983.55.3.969.
[3] J. M. Peake, O. Neubauer, P. A. Della Gatta, and K. Nosaka, “Muscle damage and inflammation during recovery from exercise,” Journal of Applied Physiology, vol. 122, no. 3, pp. 559–570, 2017, doi: 10.1152/japplphysiol.00971.2016.
[4] K. Kanzaki, D. Watanabe, J. Shi, and M. Wada, “Mechanisms of eccentric contraction-induced muscle damage and nutritional supplementations for mitigating it,” Journal of Muscle Research and Cell Motility, vol. 43, no. 3, pp. 147–156, 2022, doi: 10.1007/s10974-022-09625-1.
[5] J. C. Drake, R. J. Wilson, and Z. Yan, “Molecular mechanisms for mitochondrial adaptation to exercise training in skeletal muscle,” FASEB Journal, vol. 30, no. 1, pp. 13–22, 2016, doi: 10.1096/fj.15-276337.
[6] H. Islam, B. A. Edgett, and B. J. Gurd, “Coordination of mitochondrial biogenesis by PGC-1α in human skeletal muscle: A re-evaluation,” Metabolism, vol. 79, pp. 42–51, 2018, doi: 10.1016/j.metabol.2017.11.001.
[7] C. Ulecia-Morón, Á. G. Bris, K. S. MacDowell, et al., “Chronic mild stress disrupts mitophagy and mitochondrial status in rat frontal cortex,” Journal of Translational Medicine, vol. 23, Art. no. 580, 2025, doi: 10.1186/s12967-025-06604-1.
[8] D. Ryu, L. Mouchiroud, P. A. Andreux, et al., “Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents,” Nature Medicine, vol. 22, no. 8, pp. 879–888, 2016, doi: 10.1038/nm.4132.
[9] P. A. Andreux, W. Blanco-Bose, D. Ryu, et al., “The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans,” Nature Metabolism, vol. 1, no. 6, pp. 595–603, 2019, doi: 10.1038/s42255-019-0073-4.
[10] S. Liu, D. D’Amico, E. Shankland, et al., “Effect of urolithin A supplementation on muscle endurance and mitochondrial health in older adults: A randomized clinical trial,” JAMA Network Open, vol. 5, no. 1, Art. no. e2144279, 2022, doi: 10.1001/jamanetworkopen.2021.44279.
[11] A. Singh, D. D’Amico, P. A. Andreux, et al., “Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults,” Cell Reports Medicine, vol. 3, no. 5, Art. no. 100633, 2022, doi: 10.1016/j.xcrm.2022.100633.
[12] J. Whitfield, A. K. A. McKay, N. Tee, et al., “Evaluating the impact of urolithin A supplementation on running performance, recovery, and mitochondrial biomarkers in highly trained male distance runners,” Sports Medicine, vol. 55, no. 12, pp. 3183–3200, 2025, doi: 10.1007/s40279-025-02292-5.
[13] H. Zhao, H. Zhu, H. Yun, et al., “Assessment of urolithin A effects on muscle endurance, strength, inflammation, oxidative stress, and protein metabolism in male athletes with resistance training: An 8-week randomized, double-blind, placebo-controlled study,” Journal of the International Society of Sports Nutrition, vol. 21, no. 1, Art. no. 2419388, 2024, doi: 10.1080/15502783.2024.2419388.
[14] R. B. Kreider, D. S. Kalman, J. Antonio, et al., “International Society of Sports Nutrition position stand: Safety and efficacy of creatine supplementation in exercise, sport, and medicine,” Journal of the International Society of Sports Nutrition, vol. 14, Art. no. 18, 2017, doi: 10.1186/s12970-017-0173-z.
[15] J. T. Brosnan and M. E. Brosnan, “Creatine: Endogenous metabolite, dietary, and therapeutic supplement,” Annual Review of Nutrition, vol. 27, pp. 241–261, 2007, doi: 10.1146/annurev.nutr.27.061406.093621.
[16] S. P. Bessman and P. J. Geiger, “Transport of energy in muscle: The phosphorylcreatine shuttle,” Science, vol. 211, no. 4481, pp. 448–452, 1981, doi: 10.1126/science.6450446.
[17] M. Wang and L. Yu, “Emerging evidence of urolithin A in sports nutrition: Bridging preclinical findings to athletic applications,” Frontiers in Nutrition, vol. 12, Art. no. 1585922, 2025, doi: 10.3389/fnut.2025.1585922.
[18] R. Deminice and A. A. Jordao, “Creatine supplementation reduces oxidative stress biomarkers after acute exercise in rats,” Amino Acids, vol. 43, no. 2, pp. 709–715, 2012, doi: 10.1007/s00726-011-1121-x.
[19] R. Deminice and A. A. Jordao, “Creatine supplementation decreases plasma lipid peroxidation markers and enhances anaerobic performance in rats,” Redox Report, vol. 21, no. 1, pp. 31–36, 2016, doi: 10.1179/1351000215Y.0000000020.
[20] E. S. Rawson, M. P. Conti, and M. P. Miles, “Creatine supplementation does not reduce muscle damage or enhance recovery from resistance exercise,” Journal of Strength and Conditioning Research, vol. 21, no. 4, pp. 1208–1213, 2007.
[21] B. Northeast and T. Clifford, “The effect of creatine supplementation on markers of exercise-induced muscle damage: A systematic review and meta-analysis of human intervention trials,” International Journal of Sport Nutrition and Exercise Metabolism, vol. 31, no. 3, pp. 276–291, 2021, doi: 10.1123/ijsnem.2020-0282.
[22] S. Yamaguchi, T. Inami, H. Ishida, et al., “The effect of prior creatine intake for 28 days on accelerated recovery from exercise-induced muscle damage: A double-blind, randomized, placebo-controlled trial,” Nutrients, vol. 16, no. 6, Art. no. 896, 2024, doi: 10.3390/nu16060896.
[23] N. Percie du Sert, V. Hurst, A. Ahluwalia, et al., “The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research,” PLOS Biology, vol. 18, no. 7, Art. no. e3000410, 2020, doi: 10.1371/journal.pbio.3000410.
[24] N. Percie du Sert, A. Ahluwalia, S. Alam, et al., “Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0,” PLOS Biology, vol. 18, no. 7, Art. no. e3000411, 2020, doi: 10.1371/journal.pbio.3000411.
[25] S. A. Bustin, J. M. Ruijter, M. J. B. van den Hoff, et al., “MIQE 2.0: Revision of the Minimum Information for Publication of Quantitative Real-Time PCR Experiments guidelines,” Clinical Chemistry, vol. 71, no. 6, pp. 634–651, 2025, doi: 10.1093/clinchem/hvaf043.
[26] P. K. Smith, R. I. Krohn, G. T. Hermanson, et al., “Measurement of protein using bicinchoninic acid,” Analytical Biochemistry, vol. 150, no. 1, pp. 76–85, 1985, doi: 10.1016/0003-2697(85)90442-7.
[27] M. Spinazzi, A. Casarin, V. Pertegato, L. Salviati, and C. Angelini, “Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells,” Nature Protocols, vol. 7, no. 6, pp. 1235–1246, 2012, doi: 10.1038/nprot.2012.058.
[28] K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001, doi: 10.1006/meth.2001.1262.
[29] J. Vandesompele, K. De Preter, F. Pattyn, et al., “Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes,” Genome Biology, vol. 3, no. 7, Art. no. research0034, 2002, doi: 10.1186/gb-2002-3-7-research0034.
[30] Y. Benjamini and Y. Hochberg, “Controlling the false discovery rate: A practical and powerful approach to multiple testing,” Journal of the Royal Statistical Society: Series B (Methodological), vol. 57, no. 1, pp. 289–300, 1995.

